VALSIPITY Trademark

Trademark Overview

On Wednesday, November 24, 2021, a trademark application was filed for VALSIPITY with the United States Patent and Trademark Office. The USPTO has given the VALSIPITY trademark a serial number of 97141920. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 28, 2023. This trademark is owned by Arena Pharmaceuticals, Inc.. The VALSIPITY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use to treat ulcerative colitis, diseases and disorders of the gastrointestinal tract, Crohn's disease, autoimmune diseases and dermatological diseases and disorders
valsipity

General Information

Serial Number97141920
Word MarkVALSIPITY
Filing DateWednesday, November 24, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 28, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 29, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use to treat ulcerative colitis, diseases and disorders of the gastrointestinal tract, Crohn's disease, autoimmune diseases and dermatological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 30, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameArena Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192
Party NameArena Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, August 28, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 28, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, April 26, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 26, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 26, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 26, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 26, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 24, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 29, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 29, 2022PUBLISHED FOR OPPOSITION
Wednesday, November 9, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, October 22, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 21, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 21, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 21, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 16, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 16, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 16, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 16, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 16, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, September 9, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 9, 2022NON-FINAL ACTION E-MAILED
Friday, September 9, 2022NON-FINAL ACTION WRITTEN
Tuesday, September 6, 2022ASSIGNED TO EXAMINER
Tuesday, January 25, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 25, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 25, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 30, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 27, 2021NEW APPLICATION ENTERED

Related Keywords

valsipity diseases disorders crohn tract disease autoimmune dermatological gastrointestinal preparations treat